Is APYX or NPCE more profitable?

Apyx Medical has a net margin of -14.78% compared to NeuroPace's net margin of -19.34%. Apyx Medical's return on equity of -76.60% beat NeuroPace's return on equity. Company Net Margins Return on Equity Return on Assets Apyx Medical -14.78% -76.60% -13.91% NeuroPace -19.34% -105.64% -16.51%

Does the media refer more to APYX or NPCE?

In the previous week, NeuroPace had 1 more articles in the media than Apyx Medical. MarketBeat recorded 3 mentions for NeuroPace and 2 mentions for Apyx Medical. NeuroPace's average media sentiment score of 0.47 beat Apyx Medical's score of 0.38 indicating that NeuroPace is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Apyx Medical 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral NeuroPace 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Is APYX or SGHT more profitable?

Apyx Medical has a net margin of -14.78% compared to Sight Sciences' net margin of -35.69%. Sight Sciences' return on equity of -43.39% beat Apyx Medical's return on equity. Company Net Margins Return on Equity Return on Assets Apyx Medical -14.78% -76.60% -13.91% Sight Sciences -35.69% -43.39% -22.86%

Does the media refer more to APYX or SGHT?

In the previous week, Sight Sciences had 2 more articles in the media than Apyx Medical. MarketBeat recorded 4 mentions for Sight Sciences and 2 mentions for Apyx Medical. Apyx Medical's average media sentiment score of 0.38 beat Sight Sciences' score of 0.26 indicating that Apyx Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Apyx Medical 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Sight Sciences 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has higher earnings and valuation, APYX or CARL?

Apyx Medical has higher revenue and earnings than Carlsmed. Apyx Medical is trading at a lower price-to-earnings ratio than Carlsmed, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Apyx Medical $52.84M 2.44 -$11.21M -$0.20 N/A Carlsmed $50.51M 8.42 -$29.63M -$1.43 N/A

Is APYX or CARL more profitable?

Apyx Medical has a net margin of -14.78% compared to Carlsmed's net margin of -57.42%. Carlsmed's return on equity of -38.06% beat Apyx Medical's return on equity. Company Net Margins Return on Equity Return on Assets Apyx Medical -14.78% -76.60% -13.91% Carlsmed -57.42% -38.06% -28.96%

Does the media favor APYX or CARL?

In the previous week, Carlsmed had 2 more articles in the media than Apyx Medical. MarketBeat recorded 4 mentions for Carlsmed and 2 mentions for Apyx Medical. Carlsmed's average media sentiment score of 0.75 beat Apyx Medical's score of 0.38 indicating that Carlsmed is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Apyx Medical 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Carlsmed 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Apyx Medical (APYX) Competitors

$3.06 +0.03 (+0.99%)

Closing price 09/18/2026 04:00 PM Eastern

Extended Trading

$3.06 +0.00 (+0.16%)

As of 09/18/2026 07:54 PM Eastern

Compare

APYX vs. NPCE, TCMD, SGHT, CARL, and CLPT

Should you buy Apyx Medical stock or one of its competitors? Apyx Medical's main competitors and comparable companies include NeuroPace (NPCE), Tactile Systems Technology (TCMD), Sight Sciences (SGHT), Carlsmed (CARL), and ClearPoint Neuro (CLPT). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Apyx Medical compare to NeuroPace?

Apyx Medical (NASDAQ:APYX) and NeuroPace (NASDAQ:NPCE) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, earnings, profitability, media sentiment, institutional ownership, risk and dividends.

55.3% of Apyx Medical shares are held by institutional investors. Comparatively, 78.8% of NeuroPace shares are held by institutional investors. 15.9% of Apyx Medical shares are held by insiders. Comparatively, 19.2% of NeuroPace shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Apyx Medical currently has a consensus target price of $6.60, indicating a potential upside of 115.69%. NeuroPace has a consensus target price of $19.33, indicating a potential upside of 35.39%. Given Apyx Medical's higher probable upside, equities analysts plainly believe Apyx Medical is more favorable than NeuroPace.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Apyx Medical	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.71
NeuroPace	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.90

In the previous week, NeuroPace had 1 more articles in the media than Apyx Medical. MarketBeat recorded 3 mentions for NeuroPace and 2 mentions for Apyx Medical. NeuroPace's average media sentiment score of 0.47 beat Apyx Medical's score of 0.38 indicating that NeuroPace is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Apyx Medical	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
NeuroPace	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Apyx Medical has a net margin of -14.78% compared to NeuroPace's net margin of -19.34%. Apyx Medical's return on equity of -76.60% beat NeuroPace's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Apyx Medical	-14.78%	-76.60%	-13.91%
NeuroPace	-19.34%	-105.64%	-16.51%

Apyx Medical has a beta of 1.31, suggesting that its share price is 31% more volatile than the broader market. Comparatively, NeuroPace has a beta of 1.94, suggesting that its share price is 94% more volatile than the broader market.

Apyx Medical has higher earnings, but lower revenue than NeuroPace. NeuroPace is trading at a lower price-to-earnings ratio than Apyx Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Apyx Medical	$52.84M	2.44	-$11.21M	-$0.20	N/A
NeuroPace	$99.99M	4.90	-$21.47M	-$0.57	N/A

Summary

NeuroPace beats Apyx Medical on 10 of the 17 factors compared between the two stocks.

How does Apyx Medical compare to Tactile Systems Technology?

Apyx Medical (NASDAQ:APYX) and Tactile Systems Technology (NASDAQ:TCMD) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, media sentiment, risk, dividends, profitability, analyst recommendations, institutional ownership and valuation.

In the previous week, Apyx Medical had 2 more articles in the media than Tactile Systems Technology. MarketBeat recorded 2 mentions for Apyx Medical and 0 mentions for Tactile Systems Technology. Apyx Medical's average media sentiment score of 0.38 beat Tactile Systems Technology's score of 0.00 indicating that Apyx Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Apyx Medical	Neutral
Tactile Systems Technology	Neutral

Tactile Systems Technology has a net margin of 7.10% compared to Apyx Medical's net margin of -14.78%. Tactile Systems Technology's return on equity of 11.49% beat Apyx Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Apyx Medical	-14.78%	-76.60%	-13.91%
Tactile Systems Technology	7.10%	11.49%	9.17%

Apyx Medical currently has a consensus target price of $6.60, indicating a potential upside of 115.69%. Tactile Systems Technology has a consensus target price of $38.40, indicating a potential upside of 72.97%. Given Apyx Medical's stronger consensus rating and higher probable upside, research analysts clearly believe Apyx Medical is more favorable than Tactile Systems Technology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Apyx Medical	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.71
Tactile Systems Technology	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.67

Apyx Medical has a beta of 1.31, indicating that its share price is 31% more volatile than the broader market. Comparatively, Tactile Systems Technology has a beta of 0.8, indicating that its share price is 20% less volatile than the broader market.

55.3% of Apyx Medical shares are owned by institutional investors. Comparatively, 83.4% of Tactile Systems Technology shares are owned by institutional investors. 15.9% of Apyx Medical shares are owned by company insiders. Comparatively, 2.1% of Tactile Systems Technology shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Tactile Systems Technology has higher revenue and earnings than Apyx Medical. Apyx Medical is trading at a lower price-to-earnings ratio than Tactile Systems Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Apyx Medical	$52.84M	2.44	-$11.21M	-$0.20	N/A
Tactile Systems Technology	$329.52M	1.53	$19.09M	$1.08	20.56

Summary

Apyx Medical and Tactile Systems Technology tied by winning 8 of the 16 factors compared between the two stocks.

How does Apyx Medical compare to Sight Sciences?

Apyx Medical (NASDAQ:APYX) and Sight Sciences (NASDAQ:SGHT) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, dividends, profitability, earnings, risk, analyst recommendations, media sentiment and institutional ownership.

In the previous week, Sight Sciences had 2 more articles in the media than Apyx Medical. MarketBeat recorded 4 mentions for Sight Sciences and 2 mentions for Apyx Medical. Apyx Medical's average media sentiment score of 0.38 beat Sight Sciences' score of 0.26 indicating that Apyx Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Apyx Medical	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Sight Sciences	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

55.3% of Apyx Medical shares are held by institutional investors. Comparatively, 55.5% of Sight Sciences shares are held by institutional investors. 15.9% of Apyx Medical shares are held by insiders. Comparatively, 30.4% of Sight Sciences shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Apyx Medical currently has a consensus target price of $6.60, suggesting a potential upside of 115.69%. Sight Sciences has a consensus target price of $7.88, suggesting a potential downside of 1.81%. Given Apyx Medical's stronger consensus rating and higher probable upside, equities research analysts clearly believe Apyx Medical is more favorable than Sight Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Apyx Medical	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.71
Sight Sciences	1 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.50

Apyx Medical has a net margin of -14.78% compared to Sight Sciences' net margin of -35.69%. Sight Sciences' return on equity of -43.39% beat Apyx Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Apyx Medical	-14.78%	-76.60%	-13.91%
Sight Sciences	-35.69%	-43.39%	-22.86%

Apyx Medical has a beta of 1.31, meaning that its share price is 31% more volatile than the broader market. Comparatively, Sight Sciences has a beta of 2.5, meaning that its share price is 150% more volatile than the broader market.

Apyx Medical has higher earnings, but lower revenue than Sight Sciences. Apyx Medical is trading at a lower price-to-earnings ratio than Sight Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Apyx Medical	$52.84M	2.44	-$11.21M	-$0.20	N/A
Sight Sciences	$77.36M	5.71	-$38.43M	-$0.56	N/A

Summary

Sight Sciences beats Apyx Medical on 9 of the 17 factors compared between the two stocks.

How does Apyx Medical compare to Carlsmed?

Apyx Medical (NASDAQ:APYX) and Carlsmed (NASDAQ:CARL) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, dividends, earnings, risk, valuation and profitability.

55.3% of Apyx Medical shares are owned by institutional investors. 15.9% of Apyx Medical shares are owned by insiders. Comparatively, 12.9% of Carlsmed shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Apyx Medical has a beta of 1.31, suggesting that its stock price is 31% more volatile than the broader market. Comparatively, Carlsmed has a beta of 1.95, suggesting that its stock price is 95% more volatile than the broader market.

In the previous week, Carlsmed had 2 more articles in the media than Apyx Medical. MarketBeat recorded 4 mentions for Carlsmed and 2 mentions for Apyx Medical. Carlsmed's average media sentiment score of 0.75 beat Apyx Medical's score of 0.38 indicating that Carlsmed is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Apyx Medical	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Carlsmed	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Apyx Medical presently has a consensus price target of $6.60, suggesting a potential upside of 115.69%. Carlsmed has a consensus price target of $19.25, suggesting a potential upside of 23.56%. Given Apyx Medical's stronger consensus rating and higher probable upside, research analysts plainly believe Apyx Medical is more favorable than Carlsmed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Apyx Medical	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.71
Carlsmed	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

Apyx Medical has higher revenue and earnings than Carlsmed. Apyx Medical is trading at a lower price-to-earnings ratio than Carlsmed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Apyx Medical	$52.84M	2.44	-$11.21M	-$0.20	N/A
Carlsmed	$50.51M	8.42	-$29.63M	-$1.43	N/A

Apyx Medical has a net margin of -14.78% compared to Carlsmed's net margin of -57.42%. Carlsmed's return on equity of -38.06% beat Apyx Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Apyx Medical	-14.78%	-76.60%	-13.91%
Carlsmed	-57.42%	-38.06%	-28.96%

Summary

Apyx Medical beats Carlsmed on 10 of the 16 factors compared between the two stocks.

How does Apyx Medical compare to ClearPoint Neuro?

ClearPoint Neuro (NASDAQ:CLPT) and Apyx Medical (NASDAQ:APYX) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, institutional ownership, risk, media sentiment, valuation, profitability and analyst recommendations.

ClearPoint Neuro currently has a consensus price target of $25.67, suggesting a potential upside of 85.59%. Apyx Medical has a consensus price target of $6.60, suggesting a potential upside of 115.69%. Given Apyx Medical's stronger consensus rating and higher probable upside, analysts clearly believe Apyx Medical is more favorable than ClearPoint Neuro.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ClearPoint Neuro	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Apyx Medical	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.71

30.1% of ClearPoint Neuro shares are owned by institutional investors. Comparatively, 55.3% of Apyx Medical shares are owned by institutional investors. 6.9% of ClearPoint Neuro shares are owned by company insiders. Comparatively, 15.9% of Apyx Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, Apyx Medical had 2 more articles in the media than ClearPoint Neuro. MarketBeat recorded 2 mentions for Apyx Medical and 0 mentions for ClearPoint Neuro. Apyx Medical's average media sentiment score of 0.38 beat ClearPoint Neuro's score of 0.00 indicating that Apyx Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
ClearPoint Neuro	Neutral
Apyx Medical	Neutral

Apyx Medical has a net margin of -14.78% compared to ClearPoint Neuro's net margin of -81.76%. Apyx Medical's return on equity of -76.60% beat ClearPoint Neuro's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ClearPoint Neuro	-81.76%	-188.09%	-40.88%
Apyx Medical	-14.78%	-76.60%	-13.91%

Apyx Medical has higher revenue and earnings than ClearPoint Neuro. Apyx Medical is trading at a lower price-to-earnings ratio than ClearPoint Neuro, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ClearPoint Neuro	$36.97M	11.41	-$25.54M	-$1.18	N/A
Apyx Medical	$52.84M	2.44	-$11.21M	-$0.20	N/A

ClearPoint Neuro has a beta of 1.26, indicating that its stock price is 26% more volatile than the broader market. Comparatively, Apyx Medical has a beta of 1.31, indicating that its stock price is 31% more volatile than the broader market.

Summary

Apyx Medical beats ClearPoint Neuro on 15 of the 17 factors compared between the two stocks.

Get Apyx Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding APYX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

APYX vs. The Competition

Export

Metric	Apyx Medical	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$128.90M	$5.55B	$7.24B	$13.19B
Dividend Yield	N/A	1.80%	2.57%	12.81%
P/E Ratio	-15.30	25.34	275.49	25.40
Price / Sales	2.44	72.49	646.01	89.45
Price / Cash	N/A	32.64	76.25	51.42
Price / Book	7.85	5.69	10.46	6.33
Net Income	-$11.21M	$151.55M	$3.49B	$358.33M
7 Day Performance	5.52%	0.66%	0.59%	1.12%
1 Month Performance	0.99%	-3.33%	-1.74%	-2.39%
1 Year Performance	33.62%	6.79%	18.13%	5.35%

Apyx Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
APYX Apyx Medical	3.0476 of 5 stars	$3.06 +1.0%	$6.60 +115.7%	+33.6%	$128.90M	$52.84M	N/A	205	Positive News
NPCE NeuroPace	3.2186 of 5 stars	$14.76 -0.9%	$19.29 +30.7%	+43.7%	$511.43M	$106.99M	N/A	170	News Coverage Positive News Analyst Forecast
TCMD Tactile Systems Technology	3.4997 of 5 stars	$21.73 -0.6%	$38.40 +76.7%	+57.9%	$495.41M	$329.52M	20.12	1,086	Positive News
SGHT Sight Sciences	1.3178 of 5 stars	$8.10 -3.0%	$7.88 -2.8%	+122.8%	$459.98M	$77.36M	N/A	210	News Coverage
CARL Carlsmed	2.9509 of 5 stars	$15.23 -2.4%	$19.25 +26.4%	+10.1%	$425.92M	$50.51M	N/A	100

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:APYX) was last updated on 9/20/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Apyx Medical (APYX) Competitors

APYX vs. NPCE, TCMD, SGHT, CARL, and CLPT

How does Apyx Medical compare to NeuroPace?

Summary

How does Apyx Medical compare to Tactile Systems Technology?

Summary

How does Apyx Medical compare to Sight Sciences?

Summary

How does Apyx Medical compare to Carlsmed?

Summary

How does Apyx Medical compare to ClearPoint Neuro?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

APYX vs. The Competition

Apyx Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Apyx Medical (APYX) Competitors

APYX vs. NPCE, TCMD, SGHT, CARL, and CLPT

How does Apyx Medical compare to NeuroPace?

Do institutionals & insiders believe in APYX or NPCE?

Do analysts prefer APYX or NPCE?

Does the media refer more to APYX or NPCE?

Is APYX or NPCE more profitable?

Which has more risk and volatility, APYX or NPCE?

Which has higher valuation and earnings, APYX or NPCE?

Summary

How does Apyx Medical compare to Tactile Systems Technology?

Does the media refer more to APYX or TCMD?

Is APYX or TCMD more profitable?

Do analysts rate APYX or TCMD?

Which has more volatility & risk, APYX or TCMD?

Do insiders & institutionals hold more shares of APYX or TCMD?

Which has higher earnings & valuation, APYX or TCMD?

Summary

How does Apyx Medical compare to Sight Sciences?

Does the media refer more to APYX or SGHT?

Do institutionals and insiders hold more shares of APYX or SGHT?

Do analysts recommend APYX or SGHT?

Is APYX or SGHT more profitable?

Which has more volatility & risk, APYX or SGHT?

Which has preferable valuation and earnings, APYX or SGHT?

Summary

How does Apyx Medical compare to Carlsmed?

Do insiders & institutionals have more ownership in APYX or CARL?

Which has more volatility and risk, APYX or CARL?

Does the media favor APYX or CARL?

Do analysts prefer APYX or CARL?

Which has higher earnings and valuation, APYX or CARL?

Is APYX or CARL more profitable?

Summary

How does Apyx Medical compare to ClearPoint Neuro?

Do analysts prefer CLPT or APYX?

Do insiders and institutionals hold more shares of CLPT or APYX?

Does the media refer more to CLPT or APYX?

Is CLPT or APYX more profitable?

Which has preferable earnings and valuation, CLPT or APYX?

Which has more risk and volatility, CLPT or APYX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

APYX vs. The Competition

Apyx Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools